Conventional High Volume Hemofiltration for Hypertriglyceridemic Pancreatitis
Journal Title: Journal of Clinical Nephrology and Renal Care - Year 2017, Vol 3, Issue 1
Abstract
Several therapies have been proposed for the treatment of Hypertriglyceridaemic Pancreatitis; an uncommon cause (1-4%) of acute pancreatitis in which physio-pathology is unclear. Different combinations of medical drugs have been used to reduce hypertriglyceridaemia. Plasmapheresis is an invasive but effective alternative for severe cases but it is an expensive and not very accessible option in most of the centres. Other therapies have been considered like hemofiltration plus hemoperfusion but a standardised technique has not been established. Here, we report a 45-year-old female patient with recurrent episodes of pancreatitis related to hypertriglyceridaemia who was successfully managed in her last episode with conventional high-volume hemofiltration.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP354081
- DOI 10.23937/2572-3286.1510020
- Views 91
- Downloads 0
A Self-Sufficiency Philosophy for Non-Communicable Disease Control
A non-communicable disease comprising various vascular diseases namely renal microvascular disease, cerebrovascular disease, and coronary vascular disease, has been a threatening public health problem today. The failure...
Anti-Glomerular Basement Membrane Disease: A Case Report of an Uncommon Entity with Atypical Histological Findings
Anti-glomerular basement membrane disease is one of the infrequently encountered nephritic disorders, but one which can lead to poor renal and patient survival. Recent reports have noted the occurrence of anti-GBM diseas...
Sepsis and Renal Replacement Therapy
Sepsis has long been recognized as the most common cause of Acute Kidney Injury (AKI), present in approximately 11-40% of patients who are admitted to intensive care units.
Evaluation of Ultrasensitive C-Reactive Protein as a Cardiovascular Risk Marker in Pediatric Patients with End-Stage Renal Disease on Peritoneal Dialysis
Background Patients with End-Stage Renal Disease (ESRD) on Peritoneal Dialysis (PD) experience high morbidity and mortality due to Cardiovascular (CV) disease. In pediatric patients, CV problems include Left Ventricular...
Effects of Two Types of Protein Supplementation in Patients on Peritoneal Dialysis
Introduction Protein-energy malnutrition is one of the main problems and presents a multifactorial cause in peritoneal dialysis patients. Objective To evaluate the effects of two types of protein supplementation in pati...